Literature DB >> 1705956

Altered protein tyrosine phosphorylation in Alzheimer's disease.

I P Shapiro1, E Masliah, T Saitoh.   

Abstract

The activity of protein tyrosine kinase was determined in extracts from Alzheimer's disease brains and age- and postmortem time-matched control brains at autopsy using the synthetic peptide substrate poly(Glu4Tyr1). The specific activity of protein tyrosine kinases in the particulate fraction decreased roughly twofold (p less than 0.02) in Alzheimer's disease frontal cortex relative to unaffected control cortex. Cytosolic protein tyrosine kinase activity in Alzheimer's disease tissue was not significantly different from that in control tissue. In contrast to reduced particulate protein tyrosine kinase activity, analysis of Western blots of cytosolic and particulate fractions revealed increases in cytosolic antiphosphotyrosine immunoreactive polypeptides with molecular masses of 55 and 60 kDa. Quantitative immunohistochemistry and morphometry of frontal cortex sections with the antiphosphotyrosine antibody indicated increased antiphosphotyrosine staining in the neurons, although the number of antiphosphotyrosine-positive neurons per square millimeter decreased. Also, increased antiphosphotyrosine staining was observed in the hippocampal neurons. These results suggest that altered protein tyrosine kinases and protein tyrosine phosphorylation are involved in the pathology of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705956     DOI: 10.1111/j.1471-4159.1991.tb11405.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  A possible link between astrocyte activation and tau nitration in Alzheimer's disease.

Authors:  Juan F Reyes; Matthew R Reynolds; Peleg M Horowitz; Yifan Fu; Angela L Guillozet-Bongaarts; Robert Berry; Lester I Binder
Journal:  Neurobiol Dis       Date:  2008-05-02       Impact factor: 5.996

Review 2.  Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

Authors:  L W Jin; T Saitoh
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

3.  Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens.

Authors:  E E Lower; R S Franco; M A Miller; O J Martelo
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Increased Protein Tyrosine Phosphorylation in Apoptotic Neural Cell Death Due to Microtubule Perturbations.

Authors:  Brett A Chromy; Mary P Lambert; William L Klein
Journal:  Neurotox Res       Date:  2000-12       Impact factor: 3.911

Review 5.  Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.

Authors:  J P Huston; R U Hasenöhrl; F Boix; P Gerhardt; R K Schwarting
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease.

Authors:  E Masliah; M Mallory; L Hansen; M Alford; T Albright; R Terry; P Shapiro; M Sundsmo; T Saitoh
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients.

Authors:  Ebbe T Poulsen; Filomena Iannuzzi; Helle F Rasmussen; Thorsten J Maier; Jan J Enghild; Arne L Jørgensen; Carmela Matrone
Journal:  Front Mol Neurosci       Date:  2017-03-15       Impact factor: 5.639

8.  Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau.

Authors:  Nadine Ait-Bouziad; Anass Chiki; Galina Limorenko; Shifeng Xiao; David Eliezer; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2020-04-27       Impact factor: 5.157

9.  Computational identification and analysis of neurodegenerative disease associated protein kinases in hominid genomes.

Authors:  Saranya Jayapalan; Devika Subramanian; Jeyakumar Natarajan
Journal:  Genes Dis       Date:  2016-04-23

10.  Integrative computational evaluation of genetic markers for Alzheimer's disease.

Authors:  Zhe Li; ZhenZhen Xiong; Lydia C Manor; Hongbao Cao; Tao Li
Journal:  Saudi J Biol Sci       Date:  2018-05-18       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.